Presentación de Publicaciones Relevantes en la SVPD (2025).

Moderadores:
​Dr. Rodrigo Jover. Hospital General Universitario Dr. Balmis, Alicante.
Dr. Fernando Sábado. Consorcio Hospitalario Provincial de Castellón.

1. Subcutaneous Infliximab Cutoff Points in Patients With Inflammatory Bowel Disease: Data From the ENEIDA Registry. Iborra S M, Caballol B, Garrido A, Huguet JM, Mesonero F, Ponferrada Á, Arias García L, Boscá Watts MM, Fernández Prada SJ, Brunet Mas E, Gutiérrez Casbas A,Cerrillo E, Ordás I, Ruiz L, García de la Filia I, Escobar Ortiz J, Sicilia B, Ricart E, Domènech E, Nos P. J Crohns Colitis. 2025 Jan 11;19(1):jjae127
2. Assessing inflammatory bowel disease monitoring procedures in Spain: insights from the IBD-PODCAST study. Huguet JM, Gómez Delgado E, Rubio S, Suárez Álvarez P, Vera Mendoza I,Paredes JM, Hernández Camba A, Plaza Santos R, Mañosa M, Pajares Villarroya R, Madero Velázquez L, Vega P, Santos de Lamadrid R, Michelena N, García M,Gomollón F. Rev Esp Enferm Dig. 2025 Nov;117(11):636-644.
3. Environmental footprint and material composition comparison of singleuse and reusable duodenoscopes. López-Muñoz P, Martín-Cabezuelo R, Lorenzo-Zúñiga V, García-Castellanos M, Vilariño-Feltrer G, Tort-Ausina I, Campillo-Fernández A, Pons Beltrán V. Endoscopy. 2025 Feb;57(2):116-123.
4. Cytomegalovirus Reactivation Is Associated With Lower Rates of Hepatocellular Carcinoma Recurrence After Liver Transplantation. Aguilera V, Romero Moreno S, Conde I, Rubín A, Carvalho-Gomes A, Romero M, Zamora-Olaya J, Gómez-Bravo MA, Fuentes-Valenzuela E, Dopazo C, Bilbao N, González A, Sánchez-Martínez A, Pascual S, RiveraEsteban J, Herrero JI, Lorente S, Cuadrado-Lavín A, Nogueras F, MartínezArenas L, González-Grande R, Berenguer M, Rodriguez-Perálvarez M. Transpl Int. 2025 Jun 10;38:14553.
5. Evaluation of the PAN-PROMISE Symptom Scale in a Randomized Controlled Trial of Fluid Resuscitation in Acute Pancreatitis. Guilabert L, Cárdenas-Jaén K , Buxbaum J L, Ana García García de Paredes A, VailloRocamora A, Donate-Ortega J, Tavío- Hernández E, Lozada-Hernández EE, Hinojosa Ugarte D, Lira-Aguilar A, Pedregal Pascual P, Metha RM, Adhvaryu DD, Navarro Cortés P, pascual Moreno I, Sánchez Martín C, Cobreros-Del-Caz M, Fernández Cabrera I, Casals Seone F, Casas Deza D, Lauret –Braña E, García Gómez A, Camacho Montaño LM, Ruiz-Clavijo García D, González de la Hera Carnicer B, BoladoF, Jover R, Mira JJ, deMadaria E. Am J Gastroenterol 2025;120:1852–1859.
6. Leishmaniasis in Patients With Inflammatory Bowel Disease: A National Multicenter Study of GETECCU. L Madero‐Velázquez, A Mínguez, L Mayorga, JJ Ramírez, N Moreno, C Amorós, MA Nieto, R Mena, JM Benítez, L Gimeno‐Pitarch, N Maroto, C Suria, F Rodríguez‐Moranta, I Ordás, L Ruiz, MA García‐Brenes, A MartínCardona, C Rubín de Célix, K Cárdenas, D Ginard, L Medina, N Pedrero, R Plaza, R Salmoral, TJ Martínez‐Pérez, V Algara, E Merino, Y Zabana, A Gutiérrez28 | on behalf of Young Group of GETECCU. United European Gastroenterology Journal, 2025; 00:1–11 1 of 11
7. Identification of Candidates for MASLD Treatment With Indeterminate Vibration-Controlled Transient Elastography. Marti-Aguado D, Carot-Sierra JM, Villalba-Ortiz A, Siddiqi H, Vallejo-Vigo RM, Lara-Romero C, Martín-Fernández M, Fernández-Patón M, Alfaro-Cervello C, Crespo A, Coello E, Merino-Murgui V, Madamba E, Benlloch S, Pérez-Rojas J, Puglia V, Ferrández A, Aguilera V, Monton C, Escudero-García D, Lluch P, Aller R, Loomba R, Romero-Gomez M, Marti- Bonmati L. Clin Gastroenterol Hepatol. 2025 Jun;23(7):1183-1193.e5.
8. Monitoring Structural Bowel Damage in Patients With Crohn’s Disease Using Intestinal Ultrasonography: Can It Be Reversed by Biological Treatment? Sara Albert, Pilar Marqués Ángela Algarra, Esther Blanch, María Jesús Pérez, José Richart, José María Paredes. Inflamm Bowel Dis2025 Oct 1;31(10):2833-2839.